This article is more than 5 years old. Information may no longer be current.

Medtronic completes acquisition of Kanghui Holdings

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Medtronic Inc. has completed its acquisition of China Kanghui Holdings, a provider of orthopedic devices in China.

According to a company press release, Medtronic paid approximately $816 million in cash under the terms of the agreement announced on Sept. 27. The total value of the transaction, net of Kanghui’s cash, is expected to be approximately $755 million. The transaction was approved by Kanghui’s shareholders, and all of the other conditions to the completion of the transaction have been satisfied.

“The integration of Kanghui provides Medtronic a strong position in China’s rapidly expanding orthopedics segment, as well as a high potential platform for development of a global value segment in orthopedics,” Chris O’Connell, executive vice president and president of Medtronic’s Restorative Therapies Group, including the Spine, Neuromodulation, Diabetes and Surgical Technologies businesses, stated in the release.